Incensus Pharma IvS: Financial statements 2017
CVR: 37162949
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Incensus Pharma IvS (CVR 37162949) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,250 and a net result of DKK -1,271. Equity in the 2017 report amounted to DKK -2,767.
- Gross Profit
- DKK -1,250
- Profit/Loss
- DKK -1,271
- Equity
- DKK -2,767
- Total Assets
- DKK 4
Official annual report
Keep an eye on Incensus Pharma IvS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Incensus Pharma IvS has published its interim report for the period October 16, 2015 – December 31, 2016.
About Incensus Pharma IvS
Incensus Pharma IvS was a Danish company of the type Iværksætterselskab based in Hinnerup, founded in 2015. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.